Short stature and truncal shortening in transfusion dependent thalassemia patients: Results from a Thalassemia Center in Malaysia

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 32, Issue 3, 2001, Pages 625-630

  Hamidah, A ^a   Rahmah, R ^a   Azmi, T ^a   Aziz, J ^b   Jamal, Rahman ^a,c  

^a DEPARTMENT OF PHARMACOLOGY   (Malaysia)

^b UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^c UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; BLOOD TRANSFUSION; BODY HEIGHT; CASE CONTROL STUDY; CHILD; FEMALE; HUMAN; INFANT; MALAYSIA; MALE; NEWBORN; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PREVALENCE; THALASSEMIA;

ADOLESCENT; BLOOD TRANSFUSION; BODY HEIGHT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALAYSIA; MALE; PREVALENCE; THALASSEMIA;

EID: 0035469472     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Cazzola M, De Stefano P, Ponchio L, et al. Relationship between transfusion regimen and suppression of erythropoiesis in beta thalassemia major. Br J Haematol 1995; 89: 473-8.
2. rd ed. Churchill Livingstone, 1966; 317-9.
3. Kattamis C, Liakopoulou T, Kattamis A. Growth and development in children with thalassemia ma jor. Acta Paediatr Scand 1990; 366 (suppl): 111-7.
4. Kwan EYW, Lee ACW, Li AMC, et al. A cross-sectional study of growth, puberty and endocrine function in patients with thalassemia major in Hong Kong. J Paediatr Child Health 1995; 31: 83-7.
5. Low LCK. Hormone and growth abnormalities in untreated and treated beta thalassemia. J Pediatr Endocrinol Metab 1997; 10: 175-80.
6. Low LCK, Kwan EYW, Lim YJ, et al. Growth hormone treatment of short Chinese children with beta-thalassemia major without GH deficiency. Clin Endocrinol 1995; 42: 359-63.
7. Modell B, Berdoukas V. Growth, puberty and endocrinopathy: The clinical approach to thalassemia. London: Grune & Stratton, 1981; 175-97.
8. th ed, Vol 1: 783-857.
9. Olivieri NF, Basran RK, Talbot AL, et al. Abnormal growth in thalassemia major associated with deferioxamine-induced destruction of spinal cartilage and compromise on sitting height. [Abstract]. Blood 1995; 86 (suppl 1): 482a.
10. Olivieri NF and Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood 1997; 89: 3:739-61.
11. Rodda CP, Reid ED, Johnson S, et al. Short stature in homozygous beta thalassemia is due to disproportionate truncal shortening. Clin Endocrinol 1995; 42: 587-92.
12. Tanner. JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965, Part II. Arch Dis Child 1966; 41: 613-35.